Clinical trial · Observational
Development of a Screening Tool to Detect and Stage Cachectic Cancer Patients
NCT01533909CI-TRIAL-00016226completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study is to develop a screenings tool that will enable hospital nurses to detect and stage cancer cachectic patients. The early detection and staging of cancer cachexia will assist the oncology team in providing the cachectic cancer patient tailor-made patient care.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cachexia | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Cancer patients
- description
- As this is not an intervention study there is only one cohort. Patients that will be included and excluded are described in the eligibility section.
Primary outcomes (1)
- measure
- Nutritional Assessment
- timeFrame
- 4 times in 6 months
- description
- Patient-Generated Subjective Global Assessment Instrument is a measure for the nutritional status of the participants. The final score of this instruments devides participants into three categories: well-nourished, moderately nourished or suspected malnourished.
Secondary outcomes (3)
- measure
- Quality of Life
- timeFrame
- 4 times in 6 months
- description
- The EORTC-QlQ questionnaire will be used to assess the quality of life of the participants.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 95 Years
Show eligibility criteria text
Inclusion Criteria: * New Diagnosed Patients With Primary Head and Neck Cancer Neoplasms * New Diagnosed Patients With Metastatic Pancreatic Neoplasms * New Diagnosed Patients With Metastatic Colonic Neoplasms Exclusion Criteria: * Patients With Other Primary Neoplasms * Patients Already in Therapy * Patients With Non-metastatic Colonic or Pancreatic Neoplasms
References
Publications (0)
Data not yet available
No reference posted for this study.